The ISSM and the Sexual Medicine Society of North America (SMSNA) will focus on sexual health and cancer at their first Sexual Health Symposium next month in Kenya. 

In collaboration with the HCG-CCK Cancer Centre, the Kenyan Association of Urological Surgeons (KAUS), and the Faraja Cancer Support Trust, the event will take place November 22, 2019 at the Radisson Blu Hotel in Nairobi. 

"Our goal is to make the Sexual Health Symposium in Nairobi a first in a series of activities that can ultimately result in the development of clinical and academic collaborations throughout Kenya, and more generally across Africa," the organizers wrote. 

More information on the symposium, including the program and a link to registration details, is available here. 

Postmenopausal women with hypoactive sexual desire disorder (HSDD) may benefit from testosterone therapy, according to a recent position statement endorsed by 11 medical organizations. 

The ISSM and the International Society for the Study of Women’s Sexual Health (ISSWSH) are among the groups endorsing the statement, which provides guidelines for the use of testosterone in older women. 

Doses should "approximate physiological testosterone concentrations for premenopausal women," the authors indicated.  

Please see further details on the guidelines here.